Search
Displaying 1 result
Efanesoctocog alfa
go.drugbank.com/drugs/DB16662
ApprovedInvestigational
Efanesoctocog alfa (BIVV001) is a recombinant factor VIII (FVIII) analogue fusion protein used for the routine prophylaxis, perioperative management of bleeding and on-demand treatment and control of bleeding episodes in patients with hemophilia A. The use of FVIII replacement products is beneficial in patients with...